In PLoS Clinical Trials, volume 1, issue 1, doi: 10.1371/journal.pctr.0010003:
The following competing interest was declared by the author on submission, but due to an error the text was not included in the published version of the article: “Sean Emery receives research support from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Chiron, GlaxoSmithKline, Merck Sharpe and Dohme, and Roche.”